Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 29 Apr 2019 for Anixa Biosciences Inc, €3,396.
Filing timeline
BuySaleJohn J. Monahan
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -51.9%Entry US$4.16 · Close at T+365 US$2.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John J. Monahan: trading record in brief
John J. Monahan discloses dealings in 2 companies, chiefly Heat Biologics, Inc. and Anixa Biosciences Inc. Between 29 July 2013 and 29 April 2019, the trades on record add up to 5 filings.
Every open-market trade on record is a purchase: 1 purchase worth €3,396, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants. In 2019 alone, the filings show 1 purchase and no sales.
The newest entry dates from 29 April 2019: an open-market purchase of €3,396, in Anixa Biosciences Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to John J. Monahan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
900 shares@ US$4.22100.0% of flowCommon StockSEC:0001513162-19-000116:0
Canonical exit: 28 Jul 2019 (T+90)
50,000 sharesCommon StockSEC:0001513162-17-000266:0
3,958 sharesCommon StockSEC:0001553350-17-000461:0
51 sharesCommon StockSEC:0001553350-13-000463:1
1,160 sharesCommon StockSEC:0001553350-13-000463:0
5 of 5 declarations
